Havana, Cuba.-Specialists of the Center of Genetic Engineering and Biotechnology (CIGB) created a new medicine called Heberferon, directed principally to reduce or to eliminate the non-melanoma skin tumors. Heberferon is the synergic combination of Interferon alpha 2b and gamma recombinants. The securing of this product will be of big usefulness in the country, since in […]